Bonspri Solution for Injection
परिचय
Bonspri Solution for Injection is administered subcutaneously (under the skin). Administer the medicine as prescribed and do not skip any doses, as consistency helps maintain its effectiveness. To get the most benefit, follow up with your doctor regularly, stay up to date with vaccinations before starting treatment, and monitor for any signs of infection.
Common side effects of Bonspri Solution for Injection include injection-site reactions such as redness, swelling, or pain, as well as flu-like symptoms like fever, headache, chills, and fatigue, especially after the first doses. These symptoms usually improve with time. Some people may experience upper respiratory infections or urinary tract infections. Staying hydrated and practicing good hygiene can help reduce the risk. If side effects become severe or do not go away, consult your doctor for guidance.
Since Bonspri Solution for Injection lowers certain immune cells, it can increase the risk of infections, including serious ones like hepatitis B reactivation or upper respiratory infections. Before starting treatment, your doctor may check for infections and ensure your vaccinations are up-to-date. Avoid live vaccines while on treatment with Bonspri Solution for Injection, as they may not be safe. If you develop signs of infection, such as a persistent fever, sore throat, or unusual tiredness, seek medical advice promptly. People with a weakened immune system or a history of hepatitis B should discuss risks with their doctor before starting Bonspri Solution for Injection.
Pregnant or breastfeeding women should consult their doctor before using Bonspri Solution for Injection, as it may harm the baby. Both men and women should use effective contraception during treatment to prevent pregnancy. Bonspri Solution for Injection is a strong medication, so always follow your doctor's advice and report any concerns promptly to ensure the best results while minimizing risks.
Uses of Bonspri Solution for Injection
- बार-बार होने वाला मल्टीपल स्केलेरोसिस (एमएस) का इलाज
Benefits of Bonspri Solution for Injection
बार-बार होने वाला मल्टीपल स्केलेरोसिस (एमएस) के इलाज में
Side effects of Bonspri Solution for Injection
Common side effects of Bonspri
- सिरदर्द
- बुखार
- मांसपेशियों में दर्द
- ठंड लगना
- थकान
- इंजेक्शन वाली जगह पर रिएक्शन (दर्द, सूजन, लालिमा)
- श्वसन तंत्र के उपरी हिस्से में संक्रमण
- यूरिनरी ट्रैक्ट इन्फेक्शन
How to use Bonspri Solution for Injection
How Bonspri Solution for Injection works
सुरक्षा संबंधी सलाह
What if you forget to take Bonspri Solution for Injection
सभी विकल्प
ख़ास टिप्स
- Administer Bonspri Solution for Injection as prescribed to maintain effectiveness. Set reminders if needed.
- Report any signs of infection, such as fever, cough, or sore throat, to your doctor.
- Get necessary vaccines at least 4 weeks before starting treatment, and avoid live vaccines during treatment.
- Use birth control during treatment and for at least 6 months after stopping.
- Drink plenty of water and rest to ease flu-like side effects.
- Follow up regularly with your doctor to monitor progress and manage side effects early.
फैक्ट बॉक्स
Disclaimer:
टाटा 1mg's का एकमात्र उद्देश्य यह सुनिश्चित करना है कि उसके उपभोक्ताओं को एक्सपर्ट द्वारा जांच की गई, सटीक और भरोसेमंद जानकारी मिले. हालांकि, यहां निहित जानकारी का उपयोग एक योग्य चिकित्सक की सलाह के लिए विकल्प के रूप में नहीं किया जाना चाहिए. यहां दिए गए विवरण सिर्फ़ आपकी जानकारी के लिए हैं. यह संभव है कि इसमें स्वास्थ्य संबधी किसी विशेष समस्या, लैब टेस्ट, दवाओं और उनके सभी संभावित दुष्प्रभावों, पारस्परिक प्रभाव और उनसे जुड़ी सावधानियां एवं चेतावनियों के बारे में सारी जानकारी सम्मिलित ना हो। किसी भी दवा या बीमारी से जुड़े अपने सभी सवालों के लिए डॉक्टर से संपर्क करें. हमारा उद्देश्य डॉक्टर और मरीज के बीच के संबंध को मजबूत बनाना है, उसका विकल्प बनना नहीं.रिफरेंस
- Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1747-48.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1011.